STOCK TITAN

Charlotte's Web Reschedules Q3-2022 Earnings Call and Webcast Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Charlotte's Web Holdings, Inc. has rescheduled its Q3-2022 financial results release to 5:00 PM EST on November 14, 2022, followed by a conference call on November 15, 2022, at 10:00 AM EST. Stakeholders can participate via phone or a live webcast. The call will be accessible for replay until November 22, 2022. The adjustments are due to unexpected scheduling conflicts. Charlotte's Web remains the market leader in hemp extract wellness products, emphasizing quality and innovation in its offerings.

Positive
  • Market leader in hemp extract wellness products.
  • Upcoming Q3-2022 earnings call set for November 14, 2022.
Negative
  • Rescheduling of Q3 reporting could indicate internal operational challenges.

DENVER, Nov. 7, 2022 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in cannabidiol (CBD) hemp extract wellness products, notifies its stakeholders that due to unexpected scheduling conflicts, it has rescheduled the reporting dates for its third-quarter financial results and analyst call.

Charlotte's Web will issue its Q3-2022 financial results at 5:00pm Eastern Standard Time November 14, 2022. A conference call to discuss the results is scheduled for the following day at 10:00 a.m. Eastern Standard Time. To participate in the call, please dial 1-416-764-8659 or 1-888-664-6392 approximately 10 minutes before the conference call and provide confirmation number 24797121 or listen to the live webcast online.   

Earnings Call Replay

A recording of the call will be available through November 22, 2022.  To listen to a replay of the earnings call please dial 1-416-764-8677 or 1-888-390-0541 and provide conference replay ID 797121. A webcast of the call will also be accessible through the investor relations section of the Company's website for an extended period of time.   

About Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Denver, is the market leader in innovative hemp extract wellness products. under a family of brands that includes Charlotte's Web™, CBD Medic™, and CBD Clinic™. Charlotte's Web whole-plant CBD extracts come in full-spectrum and broad-spectrum (THC-free) options, including the world's only broad-spectrum CBD certified NSF for Sport®, which is the official CBD of Major League Baseball©. Founded by the seven Stanley Brothers, ignited the CBD industry when they came to global prominence with the coverage of a young girl's astounding reaction to their hemp extract. Their advocacy changed laws, public perception, and research around the vast health potential of plant-based solutions. The Stanleys built their business with the mission to bring safe, botanical options to health seekers worldwide. Charlotte's Web branded premium quality products start with proprietary hemp genetics that are American farm-grown-grown using organic and regenerative cultivation practices. The Company's hemp extracts have naturally occurring botanical compounds including cannabidiol ("CBD"), CBC, CBG, terpenes, flavonoids, and other beneficial compounds. The Company's CW Labs R&D division advances hemp science at a center of excellence in Louisville, Colorado. Charlotte's Web product categories include CBD oil tinctures (liquid products) CBD gummies (sleep, stress, exercise recovery), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with 20+ product lot testing for quality assurance. Charlotte's Web products are distributed to more than 15,000 retailers, over 8,000 health care practitioners, and online through the Company's website at www.charlottesweb.com

© Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

Forward-Looking Information

Certain information in this news release constitutes forward-looking statements and forward-looking information within the meaning of applicable securities laws (collectively, ‎‎"forward-looking information"). In some cases, but not necessarily in all cases, forward looking information can be identified by the ‎use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", ‎‎"is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and ‎phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be ‎achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or ‎circumstances contain forward-looking information. ‎

Statements containing forward-looking information are not historical facts, but instead represent management's current ‎expectations, estimates and projections regarding the future of our business, future plans, strategies, projections, anticipated events ‎and trends, the economy and other future conditions. Forward-looking information is necessarily based on a number of opinions, ‎assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to ‎known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, ‎performance or achievements to be materially different from those expressed or implied by such statements containing forward-looking information. Although these statements containing forward-looking information are based on assumptions the Company considers to be reasonable based on the information ‎available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned ‎against placing undue reliance on forward-looking information.  

The material factors and assumptions used to develop the forward-looking information herein include, but are not limited to, international and political considerations; regulatory changes; ‎and the factors discussed throughout the "Risk Factors" section of the Company's most recently filed annual information form available on www.SEDAR.com and in the Company's most recently filed Annual Report on Form 10-K and quarterly report on Form 10-Q as amended, and other filings with the Securities and Exchange Commission available on www.SEC.gov. Except as required by applicable securities laws, the Company undertakes no obligation to publicly update any forward-looking information, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Charlotte's Web Holdings, Inc.  

THE WORLD'S MOST TRUSTED HEMP EXTRACT™ 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reschedules-q3-2022-earnings-call-and-webcast-date-301670757.html

SOURCE Charlotte''s Web Holdings, Inc.

FAQ

When will Charlotte's Web report its Q3-2022 financial results?

Charlotte's Web will report its Q3-2022 financial results at 5:00 PM EST on November 14, 2022.

What is the date and time for the Charlotte's Web Q3-2022 earnings call?

The Q3-2022 earnings call is scheduled for November 15, 2022, at 10:00 AM EST.

How can I participate in the Charlotte's Web Q3-2022 earnings call?

To participate in the Charlotte's Web Q3-2022 earnings call, dial 1-416-764-8659 or 1-888-664-6392 about 10 minutes before the call.

Is there a playback option for the Charlotte's Web Q3-2022 earnings call?

Yes, a recording of the earnings call will be available until November 22, 2022.

What is the stock symbol for Charlotte's Web?

Charlotte's Web is listed under the stock symbol CWBHF.

CHARLOTTES WEB HLDGS INC

OTC:CWBHF

CWBHF Rankings

CWBHF Latest News

CWBHF Stock Data

18.77M
144.05M
11.24%
3.21%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Louisville